Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Endometrial Adenocarcinoma: Clinicopathologic and Survival Characteristics in Yazd, Iran

  • Binesh, Fariba (Department of Pathology, Faculty of Medical Sciences, Shahid Sadoughi University of Medical Sciences) ;
  • Akhavan, Ali (Department of Radiotherapy, Faculty of Medical Sciences, Shahid Sadoughi University of Medical Sciences) ;
  • Behniafard, Nasim (Research and Development Center, Faculty of Medical Sciences, Shahid Sadoughi University of Medical Sciences) ;
  • Jalilian, Samaneh (Department of Radiotherapy, Faculty of Medical Sciences, Shahid Sadoughi University of Medical Sciences)
  • Published : 2014.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Endometrial adenocarcinoma is the most common gynecological cancer in the Western world and its incidence appears to be rising. However, population-based studies on endometrial cancer providing survival estimates by age, histology, and stage in Asia have been sparse. The aim of this study was to evaluate the clinicopathological data and survival for patients with endometrial adenocarcinoma treated at three institutions in Yazd, Iran. Materials and Methods: Medical and anatomicopathological records at the Department of Pathology and Radiotherapy of the Shahid Sadoughi University of Medical Sciences and Madar private hospital, between 2005 and 2012 were reviewed. All cases of endometrial adenocarcinoma were included. The Kaplan-Maier method was used for survival analysis and Cox proportional hazards model for multiple regression analysis. Results: The study included 84 patients. Stages I, II, III, and IV were identified in 65.4%, 21.5%, 11.9% and 1.2%, respectively. Disease-free survival rate was $73.9{\pm}3.77$ months (95% confidence interval, 64.51-83.22 months) and relapse occurred in 12.3% of the patients. The overall survival rate was $78.2{\pm}3.65$ months (95% confidence interval, 71.0-85.3 months). A multivariate analysis revealed that stage and grade were associated with overall survival. Conclusions: In this survival analysis of patients with endometrial cancer, we found that the prognosis of endometrial cancer was fair but strongly varied by stage and grade, and moderately varied by histology and age.

Keywords

References

  1. Akbayir O, Corbacioglu A, Goksedef BP, et al (2012). The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium. Gynecol Oncol, 125, 400-3. https://doi.org/10.1016/j.ygyno.2012.01.051
  2. Assaad Semaana, Rouba Ali-Fehmib, Adnan R, et al (2012). Clinical/pathologic features and patient outcome in early onset endometrial carcinoma: A population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan. Gynecol Oncol, 124, 265-9. https://doi.org/10.1016/j.ygyno.2011.09.027
  3. Ayhan A, Taskiran C, Celik C, et al (2002). The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer, Int J Gynecol Cancer, 12, 448-53. https://doi.org/10.1046/j.1525-1438.2002.t01-1-01133.x
  4. Bristow RE, Zerbe MJ, Rosenshein NB, et al (2000). Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol, 78, 85-91. https://doi.org/10.1006/gyno.2000.5843
  5. Colombo N, Preti E, Landoni F, et al (2011). Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 22, 35-9.
  6. Creasman WT, Morrow CP, Bundy BN, et al (1987). Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 60, 2035-41. https://doi.org/10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8
  7. Fleming ND, Lentz SE, Cass I, et al (2011). Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol, 120, 189-92. https://doi.org/10.1016/j.ygyno.2010.10.038
  8. Huang CY, Chen CA, Chen YL, et al (2012). Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan. PloS One, 7, 51372. https://doi.org/10.1371/journal.pone.0051372
  9. Johnson N, Bryant A, Miles T, Hogberg T, Cornes P (2011). Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev, 10, 3175.
  10. Keys HM, Roberts JA, Brunetto VL, et al (2004). A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol, 92, 744-51. https://doi.org/10.1016/j.ygyno.2003.11.048
  11. Kong A, Powell M, Blake P (2008). The role of postoperative radiotherapy in carcinoma of the endometrium. Clin Oncol, 20, 457-62. https://doi.org/10.1016/j.clon.2008.03.011
  12. Lambrou NC, Gomez-Marin O, Mirhashemi R, et al (2004). Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol Oncol, 93, 653-8. https://doi.org/10.1016/j.ygyno.2004.03.015
  13. Lukka H, Chambers A, Fyles A, et al (2006). Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review. Gynecol Oncol, 102, 361-8. https://doi.org/10.1016/j.ygyno.2006.03.008
  14. Mehasseb MK, Latimer JA (2012). Controversies in the management of endometrial carcinoma: an update. Obstet Gynecol Int, 2012, 676032.
  15. Moreau-Claeys MV, Brunaud C, Hoffstetter S, et al (2011). High dose rate vaginal brachytherapy in endometrial cancer after surgery. Cancer Radiother. 15, 169-75. https://doi.org/10.1016/j.canrad.2010.09.002
  16. Nagase S, Katabuchi H, Hiura M, et al (2010). Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol, 15, 531-42. https://doi.org/10.1007/s10147-010-0138-6
  17. Nakayama K, Nagai Y, Ishikawa M, et al (2010). Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer. Int J Clin Oncol, 15, 440-6. https://doi.org/10.1007/s10147-010-0081-6
  18. Oaknin A, Rodriguez-Freixinos V, Diaz de Corcuera I, et al (2012). SEOM guidelines for endometrial cancer. Clin Transl Oncol, 14, 512-5. https://doi.org/10.1007/s12094-012-0833-z
  19. Park JY, Seong SJ, Kim TJ, et al (2013). Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol, 121, 136-42.
  20. Podzielinski I, Randall ME, Breheny PJ, et al (2012). Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma. Gynecol Oncol, 124, 36-41. https://doi.org/10.1016/j.ygyno.2011.09.022
  21. Randall ME, Filiaci VL, Muss H, et al (2006). Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of clinical oncology : J Clinical Oncol, 24, 36-44. https://doi.org/10.1200/JCO.2004.00.7617
  22. Rosai J (2011). Female Reproductive System: Vulva-Vagina- Uterus-cervix and corpus-Fallopian tubes Ovary-Placenta. In: Rosai J, editor. Rosai and Ackerman's Surgical Pathology, Elsevier Mosby; p. 1492-98
  23. Simpkins F, Papadia A, Kunos C, et al (2013). Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. Int J Gynecol Cancer, 23, 98-104. https://doi.org/10.1097/IGC.0b013e318276d9b6
  24. Thomas MB, Mariani A, Cliby WA, et al (2007). Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol, 107, 190-3. https://doi.org/10.1016/j.ygyno.2007.05.039
  25. Wen Q, Shao Z, Yang Z (2013). Concomitant paclitaxel plus carboplatin and radiotherapy for high-risk or advanced endometrial cancer. Int J Gynecol Cancer, 23(4):685-9. https://doi.org/10.1097/IGC.0b013e3182808232
  26. Zhang C, Wang C, Feng W (2012). Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. International journal of gynecological cancer : official journal of the Int J Gynecol Cancer. 22, 1373-7. https://doi.org/10.1097/IGC.0b013e318269f68e
  27. Zorica Stanojevic BD, Ilinka Todorovska, Vekoslav Lilic, et al (2006). adjuvant chemotherapy in the treatment of endometrial cancer medicine and biology, 113, 133-8.
  28. Zuliani AC, Cairo AA, Esteves SC, et al (2011). Adjuvant radiotherapy in early stage endometrial cancer. Rev Assoc Med Bras, 57, 438-42. https://doi.org/10.1590/S0104-42302011000400019

Cited by

  1. Roles of Sonography and Hysteroscopy in the Detection of Premalignant and Malignant Polyps in Women Presenting with Postmenopausal Bleeding and Thickened Endometrium vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5355
  2. Risk Factors of Lymph Node Metastases with Endometrial Carcinoma vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6353
  3. Lack of Relation of Survivin Gene Expression with Survival and Surgical Prognostic Factors in Endometrial Carcinoma Patients vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6905
  4. Polycystic Ovary Syndrome and Risk of Endometrial Cancer: a Mini-Review vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7011
  5. Predicting Lympho-Vascular Space Invasion in Endometrial Cancers with Mucinous Carcinomatous Components vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4247
  6. Tumor Diameter for Prediction of Recurrence, Disease Free and Overall Survival in Endometrial Cancer Cases vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7463
  7. Evaluation of Hemoglobin A1c Levels in Endometrial Cancer Patients: a Retrospective Study in Turkey vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1817
  8. Other Gynecologic Pathology in Endometrial Cancer Patients vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.713
  9. Malignancy Risk in Brazilian Women with Endometrial Polyps vol.32, pp.4, 2016, https://doi.org/10.1089/gyn.2016.0024